Xylem Reports Third Quarter 2022 Results
11/01/2022 - 06:55 AM
Lifting full-year organic revenue growth guidance to 9% to 10% , from 8% to 10%
Raising full-year adjusted EPS guidance to $2.65 to $2.75 , from $2.50 to $2.70
Third quarter revenue growth of 9% on a reported basis, 16% organically
Reported earnings per share of $0.07 , adjusted earnings per share of $0.79
WASHINGTON --(BUSINESS WIRE)--
Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter revenue of $1.4 billion , surpassing previous guidance, with strong commercial and operational execution. While orders were down 7 percent on a reported basis, they were down 1 percent organically, with the difference due to currency. The Company reported resilient underlying global demand with strong backlog growth.
Earnings also exceeded Xylem’s previous guidance, with strong margin performance. Net income was $12 million , or $0.07 per share. Net income margin decreased 810 basis points to 0.9 percent. These results were mainly driven by a previously announced, one-time non-cash pension plan settlement. Adjusted net income was $144 million , or $0.79 per share, which excludes the impacts of restructuring, realignment and special charges. Third quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 18.3 percent, reflecting a year-over-year increase of 40 basis points. Strong price realization offset inflation and, coupled with productivity savings, drove the margin expansion, exceeding the impact of strategic investments.
“The team delivered very strong performance across all our regions, driving third quarter results well above expectations on all key metrics,” said Patrick Decker , Xylem president and CEO. “Demand remains resilient across our largest end-markets, and disciplined operational execution delivered double-digit revenue growth with strong margin expansion.”
“We anticipate our momentum will continue driven by the essential nature of the services we provide. Our strong backlog and bidding pipelines support that outlook. The team, from our factories to our channel partners, continues to demonstrate resilience in managing through a dynamic environment, as our customers and communities invest in essential water infrastructure. Based on this strength, we are further raising our full-year guidance for both revenue and earnings per share, with continued confidence in Xylem’s longer-term growth outlook.”
Outlook
Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent, and approximately 4 percent on a reported basis. This represents a raise of the low end of the Company’s previous full-year organic revenue guidance of 8 to 10 percent, and 3 to 5 percent on a reported basis. Full-year 2022 adjusted EBITDA margin is now expected to be approximately 17.0 percent, raising the low end of the previous range of 16.5 to 17.0 percent. This results in adjusted earnings per share of $2.65 to $2.75 , an increase from the previous range of $2.50 to $2.70 . The increased guidance reflects strong demand, gradual easing of supply chain constraints, and price realization, partially offset by inflation and foreign exchange headwinds.
Further 2022 planning assumptions are included in Xylem’s third quarter 2022 earnings materials posted at www.xylem.com/investors . Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Third Quarter Segment Results
Water Infrastructure
Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.
Third quarter 2022 revenue was $574 million , a 5 percent increase, 13 percent organically, compared with third quarter 2021. This strong growth was driven by price realization, robust utilities demand in the US and Western Europe , and dewatering demand in the US and Emerging Markets.
Third quarter reported operating income for the segment was $104 million , a 3.0 percent increase versus the comparable period last year. Adjusted operating income for the segment, which excludes $3 million of restructuring and realignment costs, was $107 million , a 4.9 percent increase versus the comparable period last year. Reported operating margin for the segment was 18.1 percent, down 40 basis points versus the prior year, and adjusted operating margin was 18.6 percent, flat versus the prior year. Adjusted EBITDA margin was 20.7 percent, down 50 basis points from the prior year. Favorable price realization net of inflation was offset by strategic investments and unfavorable mix.
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.
Third quarter 2022 Applied Water revenue was $458 million , a 15 percent increase, 20 percent organically, year-over-year. The robust growth was driven by strong price realization and backlog execution across all end markets.
Third quarter reported operating income for the segment was $77 million , a 28.3 percent increase versus comparable period last year, and adjusted operating income, which excludes $1 million of restructuring and realignment costs, was $78 million , a 25.8 percent increase versus the comparable period last year. The segment reported operating margin was 16.8 percent, up 180 basis points versus the prior year period. Adjusted operating margin increased 150 basis points over the prior year period to 17.0 percent. Adjusted EBITDA margin was 18.1 percent, up 110 basis points from the prior year. Margin expansion was driven by strong price realization more than offsetting inflation coupled with productivity savings.
Measurement & Control Solutions
Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.
Third quarter 2022 Measurement & Control Solutions revenue was $348 million , up 9 percent, 15 percent organically, versus the prior year. While chip supply remains constrained, we continue to see modest sequential improvement, and strength in our water quality test applications.
Third quarter reported operating income for the segment was $(2) million , a 128.6 percent decrease versus the comparable period last year, and adjusted operating income, which excludes $2 million of restructuring and realignment costs and $12 million of special charges, was $12 million , a 100 percent increase versus the comparable period last year. The segment reported operating margin was (0.6) percent, down 280 basis points versus the prior year period. Adjusted operating margin of 3.4 percent increased 150 basis points over the prior year period. Adjusted EBITDA margin was 13.8 percent, down 40 basis points from the prior year. Strong price realization, volume growth and productivity savings were more than offset by higher inflation.
Supplemental information on Xylem’s third quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors .
About Xylem
Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com .
Forward-Looking Statements
This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from changes in international conditions, including as a result of the war between Russia and Ukraine , the coronavirus (“COVID-19”) pandemic and macroeconomic conditions, including inflation. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine , and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing impacts of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts, and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products; disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 ("2021 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC . In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
Three Months
Nine Months
For the periods ended September 30 ,
2022
2021
2022
2021
Revenue
$
1,380
$
1,265
$
4,016
$
3,872
Cost of revenue
856
793
2,505
2,390
Gross profit
524
472
1,511
1,482
Selling, general and administrative expenses
294
273
912
878
Research and development expenses
47
49
152
152
Restructuring and asset impairment charges (recoveries)
15
(2
)
22
7
Operating income
168
152
425
445
Interest expense
12
21
37
63
U.K. pension settlement expense
140
—
140
—
Other non-operating income, net
1
2
2
1
Gain from sale of business
—
—
1
2
Income before taxes
17
133
251
385
Income tax expense
5
19
45
71
Net income
$
12
$
114
$
206
$
314
Earnings per share:
Basic
$
0.07
$
0.63
$
1.14
$
1.74
Diluted
$
0.07
$
0.63
$
1.14
$
1.73
Weighted average number of shares:
Basic
180.2
180.2
180.2
180.2
Diluted
180.9
181.6
180.9
181.5
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
September 30 ,
2022
December 31 ,
2021
ASSETS
Current assets:
Cash and cash equivalents
$
1,186
$
1,349
Receivables, less allowances for discounts, returns and credit losses of $46 and $44 in 2022 and 2021, respectively
1,018
953
Inventories
837
700
Prepaid and other current assets
150
158
Total current assets
3,191
3,160
Property, plant and equipment, net
585
644
Goodwill
2,637
2,792
Other intangible assets, net
933
1,016
Other non-current assets
760
664
Total assets
$
8,106
$
8,276
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
618
$
639
Accrued and other current liabilities
828
752
Short-term borrowings and current maturities of long-term debt
483
—
Total current liabilities
1,929
1,391
Long-term debt
1,880
2,440
Accrued post-retirement benefits
361
438
Deferred income tax liabilities
260
287
Other non-current accrued liabilities
454
494
Total liabilities
4,884
5,050
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 196.0 shares and 195.6 shares in 2022 and 2021, respectively
2
2
Capital in excess of par value
2,123
2,089
Retained earnings
2,197
2,154
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively
(708
)
(656
)
Accumulated other comprehensive loss
(399
)
(371
)
Total stockholders’ equity
3,215
3,218
Non-controlling interests
7
8
Total equity
3,222
3,226
Total liabilities and stockholders’ equity
$
8,106
$
8,276
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the nine months ended September 30 ,
2022
2021
Operating Activities
Net income
$
206
$
314
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
83
90
Amortization
93
96
Share-based compensation
28
25
Restructuring and asset impairment charges
22
7
U.K. pension settlement
140
—
Gain from sale of business
(1
)
(2
)
Other, net
(9
)
3
Payments for restructuring
(7
)
(21
)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables
(145
)
(78
)
Changes in inventories
(214
)
(135
)
Changes in accounts payable
47
19
Changes in accrued taxes
(12
)
—
Other, net
3
—
Net Cash – Operating activities
234
318
Investing Activities
Capital expenditures
(148
)
(127
)
Proceeds from sale of business
1
2
Proceeds from the sale of property, plant and equipment
3
1
Cash received from investments
5
—
Cash paid for investments
(9
)
—
Cash received from cross currency swaps
24
11
Other, net
1
—
Net Cash – Investing activities
(123
)
(113
)
Financing Activities
Long-term debt repaid
—
(600
)
Repurchase of common stock
(52
)
(68
)
Proceeds from exercise of employee stock options
6
15
Dividends paid
(163
)
(152
)
Other, net
(1
)
(1
)
Net Cash – Financing activities
(210
)
(806
)
Effect of exchange rate changes on cash
(64
)
(19
)
Net change in cash and cash equivalents
(163
)
(620
)
Cash and cash equivalents at beginning of year
1,349
1,875
Cash and cash equivalents at end of period
$
1,186
$
1,255
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest
$
67
$
83
Income taxes (net of refunds received)
$
57
$
71
Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the US dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
Constant Currency
(A)
(B)
(C)
(D)
(E) = B+C+D
(F) = E/A
(G) = (E - C) / A
Change
% Change
Acquisitions /
Divestitures
Change
% Change
Orders
Orders
2022 v. 2021
2022 v. 2021
FX Impact
Adj. 2022 v. 2021
Adj. 2022 v. 2021
2022
2021
Nine Months Ended September 30
Xylem Inc.
4,818
4,716
102
2
%
18
189
309
7
%
6
%
Water Infrastructure
1,985
1,873
112
6
%
0
113
225
12
%
12
%
Applied Water
1,394
1,409
(15
)
-1
%
0
45
30
2
%
2
%
Measurement & Control Solutions
1,439
1,434
5
0
%
18
31
54
4
%
3
%
Quarter Ended September 30
Xylem Inc.
1,419
1,518
(99
)
-7
%
7
82
(10
)
-1
%
-1
%
Water Infrastructure
594
623
(29
)
-5
%
0
47
18
3
%
3
%
Applied Water
409
446
(37
)
-8
%
0
20
(17
)
-4
%
-4
%
Measurement & Control Solutions
416
449
(33
)
-7
%
7
15
(11
)
-2
%
-4
%
Quarter Ended June 30
Xylem Inc.
1,684
1,660
24
1
%
5
67
96
6
%
5
%
Water Infrastructure
731
639
92
14
%
0
42
134
21
%
21
%
Applied Water
480
486
(6
)
-1
%
0
15
9
2
%
2
%
Measurement & Control Solutions
473
535
(62
)
-12
%
5
10
(47
)
-9
%
-10
%
Quarter Ended March 31
Xylem Inc.
1,715
1,538
177
12
%
6
40
223
14
%
14
%
Water Infrastructure
660
611
49
8
%
0
24
73
12
%
12
%
Applied Water
505
477
28
6
%
0
10
38
8
%
8
%
Measurement & Control Solutions
550
450
100
22
%
6
6
112
25
%
24
%
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)
(As Reported - GAAP)
(As Adjusted - Organic)
Constant Currency
(A)
(B)
(C)
(D)
(E) = B+C+D
(F) = E/A
(G) = (E - C) / A
Change
% Change
Acquisitions / Divestitures
Change
% Change
Revenue
Revenue
2022 v. 2021
2022 v. 2021
FX Impact
Adj. 2022 v. 2021
Adj. 2022 v. 2021
2022
2021
Nine Months Ended September 30
Xylem Inc.
4,016
3,872
144
4
%
9
173
326
8
%
8
%
Water Infrastructure
1,696
1,625
71
4
%
0
99
170
10
%
10
%
Applied Water
1,312
1,207
105
9
%
0
44
149
12
%
12
%
Measurement & Control Solutions
1,008
1,040
(32
)
-3
%
9
30
7
1
%
0
%
Quarter Ended September 30
Xylem Inc.
1,380
1,265
115
9
%
4
80
199
16
%
15
%
Water Infrastructure
574
547
27
5
%
0
46
73
13
%
13
%
Applied Water
458
400
58
15
%
0
21
79
20
%
20
%
Measurement & Control Solutions
348
318
30
9
%
4
13
47
15
%
14
%
Quarter Ended June 30
Xylem Inc.
1,364
1,351
13
1
%
3
60
76
6
%
5
%
Water Infrastructure
589
569
20
4
%
0
34
54
9
%
9
%
Applied Water
429
414
15
4
%
0
15
30
7
%
7
%
Measurement & Control Solutions
346
368
(22
)
-6
%
3
11
(8
)
-2
%
-3
%
Quarter Ended March 31
Xylem Inc.
1,272
1,256
16
1
%
2
33
51
4
%
4
%
Water Infrastructure
533
509
24
5
%
0
19
43
8
%
8
%
Applied Water
425
393
32
8
%
0
8
40
10
%
10
%
Measurement & Control Solutions
314
354
(40
)
-11
%
2
6
(32
)
-9
%
-10
%
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)
Q1
Q2
Q3
YTD
2022
2021
2022
2021
2022
2021
2022
2021
Total Revenue
• Total Xylem
1,272
1,256
1,364
1,351
1,380
1,265
4,016
3,872
• Water Infrastructure
533
509
589
569
574
547
1,696
1,625
• Applied Water
425
393
429
414
458
400
1,312
1,207
• Measurement & Control Solutions
314
354
346
368
348
318
1,008
1,040
Operating Income (Loss)
• Total Xylem
111
133
146
160
168
152
425
445
• Water Infrastructure
74
71
108
93
104
101
286
265
• Applied Water
59
66
61
64
77
60
197
190
• Measurement & Control Solutions
(10
)
9
(5
)
13
(2
)
7
(17
)
29
• Total Segments
123
146
164
170
179
168
466
484
Operating Margin
• Total Xylem
8.7
%
10.6
%
10.7
%
11.8
%
12.2
%
12.0
%
10.6
%
11.5
%
• Water Infrastructure
13.9
%
13.9
%
18.3
%
16.3
%
18.1
%
18.5
%
16.9
%
16.3
%
• Applied Water
13.9
%
16.8
%
14.2
%
15.5
%
16.8
%
15.0
%
15.0
%
15.7
%
• Measurement & Control Solutions
-3.2
%
2.5
%
-1.4
%
3.5
%
-0.6
%
2.2
%
-1.7
%
2.8
%
• Total Segments
9.7
%
11.6
%
12.0
%
12.6
%
13.0
%
13.3
%
11.6
%
12.5
%
Special Charges
• Total Xylem
1
2
1
0
13
1
15
3
• Water Infrastructure
0
0
0
0
0
0
0
0
• Applied Water
0
1
0
0
0
1
• Measurement & Control Solutions
0
0
1
0
12
0
13
0
• Total Segments
0
1
1
0
12
0
13
1
Restructuring & Realignment Costs
• Total Xylem
4
8
8
6
6
2
18
16
• Water Infrastructure
1
5
3
4
3
1
7
10
• Applied Water
1
1
2
2
1
2
4
5
• Measurement & Control Solutions
2
2
3
0
2
(1
)
7
1
• Total Segments
4
8
8
6
6
2
18
16
Adjusted Operating Income (Loss)
• Total Xylem
116
143
155
166
187
155
458
464
• Water Infrastructure
75
76
111
97
107
102
293
275
• Applied Water
60
68
63
66
78
62
201
196
• Measurement & Control Solutions
(8
)
11
(1
)
13
12
6
3
30
• Total Segments
127
155
173
176
197
170
497
501
Adjusted Operating Margin
• Total Xylem
9.1
%
11.4
%
11.4
%
12.3
%
13.6
%
12.3
%
11.4
%
12.0
%
• Water Infrastructure
14.1
%
14.9
%
18.8
%
17.0
%
18.6
%
18.6
%
17.3
%
16.9
%
• Applied Water
14.1
%
17.3
%
14.7
%
15.9
%
17.0
%
15.5
%
15.3
%
16.2
%
• Measurement & Control Solutions
-2.5
%
3.1
%
-0.3
%
3.5
%
3.4
%
1.9
%
0.3
%
2.9
%
• Total Segments
10.0
%
12.3
%
12.7
%
13.0
%
14.3
%
13.4
%
12.4
%
12.9
%
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q3 2022
Q3 2021
As Reported
Adjustments
Adjusted
As Reported
Adjustments
Adjusted
Total Revenue
1,380
1,380
1,265
1,265
Operating Income
168
19
a
187
152
3
a
155
Operating Margin
12.2
%
13.6
%
12.0
%
12.3
%
Interest Expense
(12
)
0
(12
)
(21
)
0
(21
)
Other Non-Operating Income (Expense)
1
1
b
2
2
1
b
3
UK Pension Buyout Settlement
(140
)
140
b
0
0
Gain/(Loss) From Sale of Business
0
0
Income before Taxes
17
160
177
133
4
137
Provision for Income Taxes
(5
)
(28
)
c
(33
)
(19
)
(2
)
c
(21
)
Net Income Attributable to Xylem
12
132
144
114
2
116
Diluted Shares
181
181
182
182
Diluted EPS
$
0.07
$
0.72
$
0.79
$
0.63
$
0.00
$
0.63
Year-over-year currency translation impact on current year diluted EPS
$
0.03
($
0.17
)
($
0.14
)
Diluted EPS at Constant Currency
$
0.04
$
0.89
$
0.93
a
Quarter-to-date: Restructuring & realignment costs of $6 million in 2022 and $2 million in 2021, as well as special charges of $13 million in 2022 ($1 million UK pension plan charges and $12 million asset impairment charges) and $1 million in 2021 for UK pension plan charges.
b
Quarter-to-date: Special non-operating charges consist of $141 million in 2022 related to UK pension plan charges and buyout settlement and $1 million in 2021 for costs related to the UK pension plan.
c
Quarter-to-date: Net tax impact on restructuring & realignment costs of $1 million in 2022 and $1 million in 2021; net tax impact on special charges of $25 million in 2022; and $2 million in 2022 and $1 million in 2021 of negative impact from tax related special benefits to GAAP tax, respectively.
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)
Q1
Q2
Q3
Year-to-Date
2022
2021
2022
2021
2022
2021
2022
2021
Net Cash - Operating Activities
($81
)
($26
)
$113
$232
$202
$112
$234
$318
Capital Expenditures - PP&E
(31
)
(22
)
(30
)
(25
)
(37
)
(33
)
(98
)
(80
)
Capital Expenditures - Software
(18
)
(17
)
(16
)
(16
)
(16
)
(14
)
(50
)
(47
)
Capital Expenditures
(49
)
(39
)
(46
)
(41
)
(53
)
(47
)
(148
)
(127
)
Free Cash Flow
($130
)
($65
)
$67
$191
$149
$65
$86
$191
Net Income
82
87
112
113
12
114
206
314
Gain/(Loss) from sale of business
1
0
0
2
0
0
1
2
Restructuring & Realignment Charges - non-cash impairment
0
(1
)
0
0
0
0
0
(1
)
UK pension buyout settlement - non-cash release from AOCI
0
0
0
0
(140
)
0
(140
)
0
UK pension buyout settlement - non-cash tax release from AOCI
0
0
0
0
23
0
23
0
Special Charges - non-cash impairment
0
(1
)
(1
)
0
(12
)
0
(13
)
(1
)
Net Income, excluding gain on sale of businesses, non-cash impairment charges and non-cash pension buyout settlement
$81
$89
$113
$111
$141
$114
$335
$314
Operating Cash Flow Conversion
-99
%
-30
%
101
%
205
%
1683
%
98
%
114
%
101
%
Free Cash Flow Conversion
-160
%
-73
%
59
%
172
%
106
%
57
%
26
%
61
%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2022
Q1
Q2
Q3
Q4
Total
Net Income
82
112
12
206
Net Income margin
6.4
%
8.2
%
0.9
%
5.1
%
Depreciation
28
28
27
83
Amortization
30
32
31
93
Interest Expense (Income), net
11
10
7
28
Income Tax Expense
16
24
5
45
EBITDA
167
206
82
455
Share-based Compensation
9
9
10
28
Restructuring & Realignment
4
8
6
18
UK Pension Settlement
-
-
140
140
Special Charges
2
3
14
19
Loss/(Gain) from sale of business
(1
)
-
-
(1
)
Adjusted EBITDA
181
226
252
659
Adjusted EBITDA Margin
14.2
%
16.6
%
18.3
%
16.4
%
2021
Q1
Q2
Q3
Q4
Total
Net Income
87
113
114
113
427
Net Income margin
6.9
%
8.4
%
9.0
%
8.5
%
8.2
%
Depreciation
30
29
31
28
118
Amortization
32
33
31
31
127
Interest Expense (Income), net
19
19
20
11
69
Income Tax Expense
27
25
19
13
84
EBITDA
195
219
215
196
825
Share-based Compensation
9
8
8
8
33
Restructuring & Realignment
8
6
2
6
22
Special Charges
3
3
2
4
12
Loss/(Gain) from sale of business
-
(2
)
-
-
(2
)
Adjusted EBITDA
215
234
227
214
890
Adjusted EBITDA Margin
17.1
%
17.3
%
17.9
%
16.2
%
17.1
%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure
2022
Q1
Q2
Q3
Q4
Total
Operating Income
74
108
104
286
Depreciation
11
11
11
33
Amortization
2
3
1
6
Other non-operating expense, excluding interest income
(4
)
1
-
(3
)
EBITDA
83
123
116
322
Share-based Compensation
1
-
-
1
Restructuring & Realignment
1
3
3
7
Adjusted EBITDA
85
126
119
330
Adjusted EBITDA Margin
15.9
%
21.4
%
20.7
%
19.5
%
2021
Q1
Q2
Q3
Q4
Total
Operating Income
71
93
101
122
387
Depreciation
11
11
11
10
43
Amortization
2
2
1
3
8
Other non-operating expense, excluding interest income
(2
)
(2
)
1
(2
)
(5
)
EBITDA
82
104
114
133
433
Share-based Compensation
1
-
1
-
2
Restructuring & Realignment
5
4
1
2
12
Adjusted EBITDA
88
108
116
135
447
Adjusted EBITDA Margin
17.3
%
19.0
%
21.2
%
21.7
%
19.9
%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water
2022
Q1
Q2
Q3
Q4
Total
Operating Income
59
61
77
197
Depreciation
5
4
4
13
Amortization
-
1
-
1
Other non-operating expense, excluding interest income
(1
)
-
(1
)
(2
)
EBITDA
63
66
80
209
Share-based Compensation
1
1
2
4
Restructuring & Realignment
1
2
1
4
Special Charges
-
-
-
-
Loss/(Gain) from sale of business
-
-
-
-
Adjusted EBITDA
65
69
83
217
Adjusted EBITDA Margin
15.3
%
16.1
%
18.1
%
16.5
%
2021
Q1
Q2
Q3
Q4
Total
Operating Income
66
64
60
50
240
Depreciation
5
5
5
5
20
Amortization
1
1
-
-
2
Other non-operating expense, excluding interest income
-
(1
)
-
(2
)
(3
)
EBITDA
72
71
65
53
261
Share-based Compensation
1
1
1
1
4
Restructuring & Realignment
1
2
2
2
7
Special Charges
1
-
-
-
1
Loss/(Gain) from sale of business
-
(2
)
-
-
(2
)
Adjusted EBITDA
75
72
68
56
271
Adjusted EBITDA Margin
19.1
%
17.4
%
17.0
%
13.8
%
16.8
%
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions
2022
Q1
Q2
Q3
Q4
Total
Operating Income
(10
)
(5
)
(2
)
(17
)
Depreciation
9
8
8
25
Amortization
25
26
27
78
Other non-operating expense, excluding interest income
-
(1
)
(1
)
(2
)
EBITDA
25
28
32
85
Share-based Compensation
1
2
2
5
Restructuring & Realignment
2
3
2
7
Adjusted EBITDA
27
34
48
109
Adjusted EBITDA Margin
8.6
%
9.8
%
13.8
%
10.8
%
2021
Q1
Q2
Q3
Q4
Total
Operating Income
9
13
7
(17
)
12
Depreciation
9
10
11
8
38
Amortization
27
27
27
26
107
Other non-operating expense, excluding interest income
(1
)
(1
)
-
-
(2
)
EBITDA
44
49
45
17
155
Share-based Compensation
1
2
1
2
6
Restructuring & Realignment
2
-
(1
)
2
3
Adjusted EBITDA
47
51
45
21
164
Adjusted EBITDA Margin
13.3
%
13.9
%
14.2
%
7.1
%
12.3
%
View source version on businesswire.com : https://www.businesswire.com/news/home/20221031005753/en/
Media
Houston Spencer +1 (914) 323-5723
houston.spencer@xylem.com
Investors
Andrea van der Berg +1 (202) 869-9151
andrea.vanderberg@xylem.com
Source: Xylem Inc.